Dokumentationen und Studien zu Medihoney™

Infomaterial zu den Medihoney Produkten

  • Medihoney™ Produktbroschüre
  • Fachinformation Medihoney™ Wundpflege
  • Gebrauchsinformation Medizinischer Honig & Wundgel
  • Gebrauchsinformation Wundverbände mit Medihoney
  • Inhaltsstoffe Medihoney Dermacreme
  • Inhaltsstoffe Medihoney Schutzcreme

Alle aufgeführten wissenschaftlichen Studien zur Wirksamkeit von medizinischem Honig beziehen sich auf die Originalprodukte von Medihoney™.

Verpackung der gesamten Medihoney Produkten.

REFERENCES FOR THE USE OF MEDIHONEY™ ANTIBACTERIAL HONEY

* Medihoney Antibakterieller Medizinischer Honig
** Medihoney Antibakterielles Wundgel
*** Medihoney Antibakterieller Alginatverband
**** Medihoney Gel Sheet
***** Medihoney Tüllverband

IN VIVO

  1. Aballay A. (2014) Rapid healing & promotion of autolytic debridement using active Leptospermum honey in deep partial thickness burns. Proceedings of ISBI Conference, Oct, Sydney Australia. Poster. (**)
  2. Acton, C. and Dunwoody, G. (2008) The use of medial grade honey in clinical practice. British Journal of Nursing. 17(20): S. 38-S. 44.(**)
  3. Acton, C. and Dunwoody, G. (2008) Honey: where should it be placed on the wound care formulary? proceedings of European Wound Management Association Conference, Lisbon, Portugal, May. Poster. (**)
  4. Acton. C. (2008) Medihoney™: a complete wound bed preparation product. British Journal of Nursing. 17(11) S44-S48 (**)
  5. Acton, C. (2008) Treatment of a venous leg ulcer found in an intravenous drug user. Wound Essentials. 3: 69-71 (**)
  6. Acuna, E. (2010) Active Leptospermum honey and negative wound pressure therapy for non-healing post-surgical wounds. American Professional Wound Care Association, Philadelphia, 8-11 April. Poster
  7. Albietz, J.M. and Lenton, L.M. (2006) Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease. Cornea. 25. (9): 1012-1019 (*)
  8. Alcaraz, A. and Kelly, J. (2002) Treatment of an infected venous leg ulcer with honey dressings. British Journal of Nursing. 11. (13): 859-866. (*)
  9. Alridge P. (2013) More than just a debriding agent: the biomodulating effects of Leptospermum scoparium in acutely-chronic wounds. Proceedings of Symposium on Advanced Wound Care, Las Vegas. Poster. (***)
  10. Amaya R. (2013) Autolytic Debridement and Healing of Neonatal and Pediatric Wounds with Active Leptospermum Honey: Case Series. Proceedings of Symposium on Advanced Wound Care, Denver, CO. Poster. (**,^^)
  11. Amaya R. (2014) Autolytic debridement and healing of pediatric burn wounds with Active Leptospermum honey. Proceedings of Symposium on Advanced Wound Care, Las Vegas, NV. Poster. (**)
  12. Amaya R. (2014) Use of Active Leptospermum Honey (ALH) to manage difficult post –operative pediatric pilonidal cyst wounds. Proceedings of Clinical Symposium on Advances in Skin & Wound Care, Las Vegas, NV. Poster. (**)
  13. Amaya R. (2015) Use of Active Leptospermum Honey to Treat Difficult Post Operative Pediatric Pilonidal Cyst Wounds. SAWC, San Antonio, Texas. Poster.
  14. Amaya R. (2015) Use of Active Leptospermum Honey (=ALH or Manuka), to treat difficult post operative
    Paediatric pilonidal cyst wounds. EWMA London. Mai. Poster.
  15. Bardsley A. (2008) The Use of Honey in Incontinence associated Dermatitis. Continence UK Vol 2, No 4.
  16. Bardy J, Molassiotis A, Ryder WD, Mais K, Sykes A, Yap B, Lee L, Kaczmarski E, Slevin N. A (2012) double-blind, placebo-controlled, randomized trial of active manuka honey and standard oral care for radiation induced oral mucositis. Br J Oral Maxillofac Surg. 50(3): 221-6. (˄)
  17. Bastos, A., Maillard, S., 7 Leschof,P. (2008) Ecology, wound…and antibacterial medial honey. Proceedings of Wounds UK. Harrogate, UK. Poster (*)
  18. Bateman, S. and Graham, T. (2007) The use of Medihoney™ Antibacterial Wound Gel on surgical wounds post coronary artery bypass grafts (CABG). Wounds UK. 3. (3): 76-83 (**)
  19. Berke Ch. T., (2012) The Effect of Active Leptospermum Honey Gel on the Wounds of Patients with Immune Compromise. Spring SAWC conference. Atlanta. April. Poster.
  20. Biglari B., Moghaddan A., Santos K., Blaser G. et al. (2012). Multicentre prospective observational study on professional wound care using honey (Medihoney TM). Blackwell Publishing Ltd and Medicalhelplines.com Inc IntWoundJ 2012
  21. Biglari B., vd Linden PH., Simon A. et al. (2011). Use of Medihoney as a non-surgical therapy for chronic pressure ulcers in patients with spinal cord injury. Spinal Cord online publication
  22. Bittmann S, Luchter E, Thiel M, Kameda G, Hanano R, Längler A. (2011) Does honey have a role in paediatric wound management? British Journal of Nursing 2011; review 19(15): 19-24.
  23. Blaser, G., Santos, K., Bode, U., Vetter, H. and Simon, A. (2007) Effect of medical honey on wounds colonised or infected with MRSA. Journal of Wound Care. 16. (8): 325-328 (*)
  24. Bodie Gross E. (2009) Active Leptospermum honey for Frostbite, PIN sites, and Infected Skin Tears. Proceedings of the Clinical Symposium on Advances in Skin and Wound Care, October 22-25, Poster (*,**,***)
  25. Bodie Gross, E. (2008) Active Leptospermum Honey impregnated calcium alginate dressing treatment options for medically compromised patients. Proceedings of World Union of Wound Healing Societies. Toronto, Canada.. Poster. (***).
  26. Boyar V. (2013) Successful treatment of slow healing neonatal wounds and skin injury with medical grade honey: a case series. Proceedings from Symposium of Advanced Wound Care, Las Vegas. Poster. (**)
  27. Boyer (2014), Clinical Experience with Leptospermum Honey use for treatment of hard to heal neonatal wounds: case series. Journal of Perinatology , 34, 161-163. (**,+)
  28. Bradley, T. (2004) “Mummy you smell like honey!”- Utilisation of Medihoney™ Antibacterial Honey in malodorous wound management. Proceedings of Australian and New Zealand palliative Care Conference. Auckland, New Zealand. Sept. (*)
  29. Bradley S. (2015) Use of antibacterial manuka honey with a rare congenital anomaly. EWMA London. Mai. Poster.
  30. Bratt K. (2013) Sweet victory of healing wounds with active Leptospermum honey and a hydrophilic dressing. Proceedings of Wild on Wounds, Las Vegas. Poster. (**)
  31. Brennan, M.R. and Faliks, S(2008) Wound healing experiences with a honey based product. Proceedings of The World Union of Wound Healing Societies. Toronto, Canada. June. Poster(***)
  32. Brennan, M. R., & Faliks, S. (2009). Honey-debriding alternative. Symposium on Advanced Wound Care. Dallas, Texas. April. Poster. (***)
  33. Bridgeman C, Hall C. (2011) Use of active Leptospermum Honey to heal pressure ulcers. A Case series of pressure ulcers. Proceedings of Clinical Symposium on Advances in Skin and Wound Care Dallas April, 2011, TX, Poster (*, ***, ****)
  34. Brooks P, McGill M. (2013) Treating complicated wounds in the acute care setting with 3 types of active Leptospermum honey. Proceedings from Symposium of Advanced Wound Care, Las Vegas. Poster. ( ^,**,***)
  35. Brown, B. (2006) Medihoney™ used to address malodour in a chronic venous leg ulcer. Tasmanian Wound Care Association Newsletter. Oct. (**)
  36. Cadogan, J. (2006) The use of honey to treat a pressure ulcer on the heel of a diabetic patient. Proceedings of Wounds UK Harrogate, Harrogate, England. November. Poster (*,**)
  37. Cadogan, J. (2008) The use of honey to treat a pressure ulcer on the heel of a person with diabetes. The Diabetic Foot Journal. 11(1):43-45. (* / **)
  38. Chaiken, N. (2009) Active Leptospermum honey for the treatment of recalcitrant lower extremity wounds. Proceedings of American professional Wound Care Association Conference. Philadelphia, USA, 2-4 April. Poster. (***)
  39. Chaiken, N. (2010) The use of active Leptospermum honey on difficult to heal wounds of various etiologies. Symposium on Advanced Wound Care and Wound Healing Society Meeting: Orlando, FL., USA. 17-20 April. Poster.
  40. Chaiken, N. (2010) Pressure ulceration and the use of Active Leptospermum Honey for debridement and healing. Ostomy Wound Management. 56(5): 12-14.
  41. Chapman, L. (2009) Use of honey on a neuropathic ulcer. Journal of Community Nursing. 23(2): 10-14 (**)
  42. Chernev, I., Liguori, P.A., Senno, S.L., Peters, K.L.and Bowers, J.M. (2010) Combined noncontact, low-frequency ultrasound and medical honey for the treatment of chronic wounds. J Wound Ostomy Continence Nurs. 37(4) (***)
  43. Chilvers, D. and Moloney, A. (2006) Antibacterial medical honey: meeting the criteria for total wound bed preparation using the time principles. Proceedings of Wounds UK Harrogate, Harrogate, England. November. Poster
  44. Cooper, J. (2009) Wound management following orbital exenteration surgery. British Journal of Nursing. 18(6 Suppl): S4-S14 (**)
  45. Day, J and Zulkowski, K. (2008) use of honey for wound healing a case study. Proceedings of Wound, Ostomy, Continence Nurses Society. Orlando, Florida. June. Poster.(***)
  46. Deo C. (2009) Evidence Based Practice for Pediatric Wound Care: Utilizing Active Leptospermum Honey as a primary dressing in chronic wounds. Proceedings of Clinical Symposium on Advances in Skin and Wound Care, Oct., 2009, Poster (*,**,***)
  47. Dillow P. (2013) Healing and Prevention of Clinically Complex Wounds in a Cancer Treatment Center Using Leptospermum. Proceedings of Oncology Nursing Society Annual Congress, Washington DC. Poster. (**,^^)
  48. Duncan C, Aballay A. (2014) Work in Progress: MH vs. Collagenase for partial thickness burns. . Work in Progress: MH vs. Collagenase for partial thickness burns. Proceedings of ISBI Conference, Sydney Australia. Poster. (**)
  49. Duncan C, Szabo M, Enlow P, Mentrikoski J, Kelly R, Aballay A. (2014) Comparison of Active Leptospermum Honey and collagenase in the treatment of partial thickness burns: an experimentally controlled case series. Proceedings of International Society for Burn Injuries, Sydney Australia. Poster. (**)
  50. Deo, C. and Packard, L. (2010) Evidence based practice for pediatric wound care: Utilizing active Leptospermum honey as a primary dressing in chronic wounds. American Professional Wound Care Association, Philadelphia, 8-11 April. Poster
  51. Drain J., Fleming M. (2015) Palliative Management of Malodorous Squamous Cell Carcinoma of the Oral Cavity with Manuka Honey. SAWC, San Antonio, Texas. Poster.
  52. Dunford, C. and Hanano, R. (2004) Acceptability to patients of a honey dressing for non-healing venous leg ulcers. Journal of Wound Care. 13. (5): 193-197. (*)
  53. Dunford, C. (2001) Treatment of a wound infection in a patient with mantle cell lymphoma. British Journal of Nursing. 10. (16): 1058-1065. (*)
  54. Dunford, C. (2005) The use of honey-derived dressings to promote effective wound management. Professional Nurse. 20. (8): 35-38. (*)
  55. Fitzmaurice SD, Sivamani RK, Isseroff RR (2011). Antioxidant therapies for wound healing: a clinical guide to currently commercially available products. Skin Pharmacol Physiol.; 24(3): 113-26. Review (*)
  56. Flavin, S., Evans, J. and James, D. (2007) Differentiating between Nicorandil induced ulceration and pressure damage. Proceedings of Wounds UK Conference. Harrogate, UK. Nov. Poster. (**)
  57. Fortner, T. T. (2009). The beneficial effects of active Leptospermum honey for chronic, non-healing wounds. Symposium on Advanced Wound Care. Dallas, Texas. April. Poster. (***)
  58. Fowler G. (2014) What’s the Buzz about Honey? Proceedings of Annual Scientific Conference, Phoenix, AZ. Poster. (*)
  59. Frykberg, R.G., Tallis, A., Thomas-Ramoutar, C. and Hayden, C.T. (2007) Manuka Honey Alginate Wound Dressing facilitates healing of chronic diabetic lower extremity ulcerations. Proceedings of New Cardiovascular Horizons Conference. New Orleans. September. Poster. (***)
  60. Gallagher K. (2015) Conservative Approaches in „At Risk“ Wound Patients. EWMA London. Mai. Poster.
  61. Gallagher K. (2015) Medical Grade Honey as an Alternative to Surgery. EWMA London. Mai. Poster.
  62. Ganacias-Acuna, E. (2009). Active Leptospermum honey and negative pressure wound therapy for non-healing post-surgical wounds.: Clinical Symposium on Advances in Skin and Wound Care. San Antonio, TX. Poster.
  63. Ganacias-Acuna, E. F. (2010) Active Leptospermum honey and negative pressure wound therapy for nonhealing postsurgical wounds. Ostomy Wound Management März: 10-11
  64. Gardner J. A., Murphy T. (2012) Turning to Active Leptospermum Honey for Debridement: Case Series. Underwood-Memorial Hospital, Woodbury, NJ. September. Poster.
  65. Gardner JA, Murphy T. (2011) Utilization of a novel active Leptospermum Honey gel dressing for debridement and healing of VLUs. Proceedings of Symposium on Advances in Skin and Wound Care, Oct. 2011, Las Vegas, NV, Poster (**)
  66. Gächter B., Probst S., Gächter J., Isaak A., Al-Muaid J., Schlunke S., Biegger P. (2012) Erfolgreiche Alternativbehandlung bei ausgedehntem nekrotischen Wundprozess – Fallbericht. Deutscher Wundkongress. Bremen. Mai. Poster.
  67. George E. A. (2015) Managing Pyoderma Gangrenosum with Leptospermum Honey. WOCN San Antonio Texas. Juni. Poster.
  68. Gethin G, Cowman S. (2005) Case series of use of Manuka honey in leg ulceration. International Wound Journal 2005;2(1):10-15. (*)
  69. Gethin G, Cowman S. (2008) Bacteriological changes in sloughy venous leg ulcers treated with manuka honey or hydrogel: an RCT. Journal of Wound Care 2008;17(6):241-247. (*)
  70. Gethin G., Cowman S. (2008) Manuka honey vs. hydrogel – a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. Journal of Clinical Nursing 2008; 18(3): 466-474. (*)
  71. Gethin G, Cowman S. and Conroy R. (2008) The impact of Manuka honey dressings on the surface pH of chronic wounds. International Wound Journal. 5(2):185-194 (***)
  72. Gethin G (2008), Influence of Manuka honey on surface pH, MMP-2, MMP-9 and wound size of chronic wounds. European Wound Management Association Conference, May, Lisbon, Portugal. Poster. (^)
  73. Gethin G (2007), Manuka Honey vs Hydrogel. Wounds UK Conference, November, Harrogate, UK. Poster. (**)
  74. Gotts, J. (2013) The Treatment of a Diabetic Heel Ulcer Using Medical Grade Honey. Proceedings of Wounds UK Conference, Nov., Harrogate, UK. Poster. (**)
  75. Grant, T. (2008) The use of Medihoney Antibacterial Wound Gel for treatment of pilonidal sinus post incision and drainage. Proceedings of Wounds UK Conference. Harrogate, England. November. Poster. (**)
  76. Grant, T. (2009) Treating pilonidal sinus wounds with an antibacterial wound gel after incision and drainage. Wounds UK. 5(1):78-80 (**)
  77. Gray C. and Ishii F. (2012) Comparing Efficacy of Active Leptospermum Honey. Spring SAWC conference. Atlanta. April. Poster.
  78. Greenwood M, Handsaker J. (2012) Honey and Medihoney® Barrier Cream: their role in protecting and repairing skin. British Journal of Community Nursing.; 17(12); pp S32-S37.
  79. Greenwood M., Handsaker J. (2012) A case study to present the clinical benefist of an active leptospermum honey Barrier Cream. Greenwood. Wounds UK. Poster.
  80. Grothier L, Cooper R. (2011) Medihoney™ Dressings made easy. Wounds UK 2011;7(4):1-6. (All Medihoney products)
  81. Gudeman J. (2012) A Cost and Value Analysis of Products in an Outpatient Wound Clinic After the Addition of Active Leptospermum Honey Products. Spring SAWC conference. Atlanta. April. Poster.
  82. Hanft, J.R., Smith, T. and Legel K. (2009) Topical active Leptospermum honey in recalcitrant venous leg wounds: A preliminary case series. Proceedings of Diabetic Foot Global Conference. Los Angeles, USA. 19-21 March. Poster. (***)
  83. Harper J (2013), Healing chronic wounds with Leptospermum honey in the Outpatient Clinic. Proceedings of Symposium on Advanced Wound Care, Spring, Denver, CO. Poster. (***)
  84. Hayes L. (2008) Leptospermum Honey Alginate Wound Dressing facilitates healing in elderly patients with painful chronic wounds unable to tolerate silver dressings. Proceedings of World Union of Wound Healing Societies. Toronto, Canada. June. Poster (***)
  85. Hendrickson, M. A. (2009). Utilizing active Leptospermum honey dressings in the treatment of cutaneous small-vessel vasculitis. Symposium on Advanced Wound Care. Dallas, Texas. April. Poster. (***)
  86. Hendrickson, M.A. (2010). Utilizing active Leptospermum honey dressings in the treatment of cutaneous small-vessel vasculitis. Ostomy Wound Management, 56(4), 10-12. (***)
  87. Hoge T. (2012) A clinical and cost comparison of Active Leptospermum Honey versus collagenase in long term care. Proceedings of Diabetic Limb Salvage Conference. Washington DC, October 2012 Poster (**)
  88. Hune S, Mierdel S, Uppal K, Smith D, Clarke C, Mainella S, Boyd S, Seto D.(2011) Innovative Interprofessional team approach to product selection and chronic wound management in long-term care home. Proceedings of Canadian Association of Wound Care. Ottawa, Canada, November Poster (***)
  89. Isaac D. L. (2015) Benefits of Using Leptospermum Honey for Oncological Wounds to Improve Patients’ Quality of Life. WOCN San Antonio Texas. Juni. Poster.
  90. Johnson C. (2013) Benefits of a Novel Hydrogel Colloidal Sheet with Leptospermum Honey. Proceedings of Symposium on Advanced Wound Care, Spring, Denver, CO. Poster. (^^)
  91. Johnson C. (2012) Pain, Odor, Dignity, Wound Management of a Complex Oncology Patient with Multiple Wounds. University Medical Center of Princeton, NJ. September. Poster.
  92. Johnson C. (2015) Leptospermum honey to promote healing in an Oncology Center. Oncology Nursing Society Congress. San Antonio. Texas. April. Poster.
  93. Johnson D, Badre S, Pascoe E, Beller E, Cass A, Clark C, deZoysa J, Isbel N, McTaggart S, Morrish A, Playford EG, Scaria A, Snelling P, Vergara L, Hawley C (2013). Antibacterial honey for the prevention of peritoneal-dialysis-related infections (Honey Pot): A randomized trial. Lancet Inf Dis. Doi: 10.1016 (**)
  94. Johnson, D.W., van Eps, C., Mudge, D.W., Wiggins, K.J., Armstrong, K.J., Hawley, C.M., Campbell, S.B., Isbel, N.M., Nimmo, G.R. and Gibbs, H. (2005) Randomized, controlled trial of topical exit-site application of honey (Medihoney™) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis. Journal of American Society of Nephrology. 16. (5): 1456-62. (*)
  95. Johnson D.W., Clark C., Isbel N.M., Hawley C.M., Beller E., Cass A., de Zoysa J., McTaggart S., Playford G., Rosser B., Thompson C., Snelling P. (2009) The Honeypot Study Protocol: A randomized controlled trial of exit-site application of Medihoney Antibacterial Wound Gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int. 29. (3):303-309. (**)
  96. Jull A, Walker N, Parag V, Molan P, Rodgers A. Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. British Journal Of Surgery 2008; 95 (2): 175-82 (***)
    105. Kallen A, Arduino M, Patel P. (2010) Preventing infections in patients undergoing hemodialysis. Expert Review of Anti-Infective Therapy;8(6):643-655. (**)
  97. Kamaratos A. V., Tzirogiannis K. N., Iraklianou S. A., Panoutsopoulos G. I., Kanellos I. E., Melidonis A. I. (2012) Manuka honey-impregnated dressings in the treatment of neuropathic diabetic foot ulcers. International Wound Journal. 10.1111/j.1742-481X.2012.01082.x (*****)
  98. Kavros, S.J. (2008) Utilizing Leptospermum Honey Alginate in the Treatment of Recalcitrant Lower Extremity Ulcerations. Proceedings of American Professional Wound Care Association Conference. Texas. USA. March. Poster. (***)
  99. Kerzner M. (2011) Novel use of active Leptospermum Honey for pin site care. Proceedings of Diabetic Limb Salvage Conference, Oct 2011, Washington DC, Poster (****)
  100. Kesselman, P. (2008) Clinical application of absorbent calcium alginate dressing pads, containing Manuka (Leptospermum) honey on infected lower extremity venous ulcers. Proceedings of American professional Wound Care Association Conference. Texas, USA, March. Poster. (***)
  101. Kesselman, P. (2009) Chronic colonized charcot foot ulcer: Clinical application of absorbent calcium alginate dressing pads, containing Manuka (Leptospermum) honey. Proceedings of American professional Wound Care Association Conference. Phildelphia, USA, 2-4 April. Poster. (***)
  102. Kroeger, K. (2008) Honig und Wundheilung. The use of medical honey in wound healing. Wund Management. 3: 64-70(*). (German)
  103. Langemo, D. Hanson, D. Anderson, J. Thompson, P. and Hunter, S. (2009) Use of Honey for Wound Healing. Advances in Skin & Wound Care. 22 (3):113-118. (***)
  104. Lässker, R., Medugno, C. and Wigger, P. (2008) Behandlung chronischer Wunden mit Honig. 95. Jahreskongress der Schweizer Gesellschft für Chirurgie. Basel, Schweiz. 28 -30 Mai. Poster (*)
  105. Larsen, T., Reif, S., & Tavernelli, K. (2009). Use of active Leptospermum honey dressings in the home care setting. Symposium on Advanced Wound Care. Dallas, Texas. April. Poster. (***)
  106. Liguori, P.A.. and Peters, K.L. (2008) Favorable treatment outcomes of painful chronic leg ulcers with the use of a new active leptospermum Honey impregnated calcium alginate dressing. Proceedings of World Union of Wound Healing Societies. Toronto, Canada. June. Poster (***)
  107. Liguori, P.A.. and Peters, K.L. (2008) A new active Leptospermum Honey impregnated calcium alginate dressing has a positive impact on a wide variety of wound types. Proceedings of World Union of Wound Healing Societies. Toronto.
  108. Ligouri, P.A. and Peters, K.L. (2008) Limb at risk: use of an active Leptospermum honey for the management of an infected foot wound complicated by cellulitis. Proceedings of Clinical Symposium of Advanced Wound Care. Las Vegas. USA. Oct. Poster(***)
  109. Lintzeris D (2013), Limb Salvage 101: Utilizing an Easier Total Contact Cast along with Active Leptospermum Honey and Advanced Wound Care Modalities to Heal Chronic Wounds of the Foot in less than 36 Days. Proceedings of Symposium on Advanced Wound Care, Spring, Denver, CO. Poster. (**)
  110. Lintzeris, D, Yarrow, K, Johnson, L, White, A, Hampton, A, Albert, K, Cook, A, Strickland, A. (2014) Holistic Approach: Wound Product Selection for the Management of Patients with Complex Challenging Wounds. Symposium on Advanced Wound Care. Poster. (**)
  111. Maggio, D. (2010) Evidence based practice: Active Leptospermum honey dressing for use in an indigent outpatient wound care clinic. American Professional Wound Care Association, Philadelphia, 8-11 April. Poster
  112. Maggio D, Graves L. (2011) The use of active Leptospermum honey in underinsured patient population wound. Proceedings of American Professional Wound Care Association, Fall, Philadelphia. Poster. (***)
  113. Mathews C. (2014) Affordable quality wound care and associated cost reduction with addition of Leptospermum honey products to formulary at urban ACO hospital. Proceedings of Symposium on Advance Wound Care, October, Las Vegas, NV. Poster. (^^, **)
  114. Milne, C. (2008) Comparison of honey impregnated alginate dressings to non-impregnated calcium alginate dressings on wound healing. Proceedings of Symposium on Advanced Wound Care. San Diego, USA.. March. Poster.(***)
    125. Mohr, L, Reyna, R. Amaya (2014). Neonatal Case Series Using Active Leptospermum Honey. J Wound Ostomy Continence Nursing; 41(3):213-218. (**,****)
  115. Moore, S. (2008) Squamous cell carcinoma using active Leptospermum Honey for wound management and odor control. Proceedings of South Central region Ostomy & Continence Society. Oklahoma, USA. September. Poster. (***)
  116. Müller J., Anagnostou S., Friedrich Ch. (2011) Honey as a vulnerary – a precious gift to mankind. Internationaler Kongress für Geschichte der Pharmazie. Berlin. September. Poster.
  117. Naidoo N, Jameson M, Molan P, Round G. (2011) A phase ll randomized controlled trial using Manuka Honey as prophylaxis against radiation-induced dermatitis in breast cancer patients. Proceedings of European Multi-disciplinary Cancer Congress, Sept 2011, Stockholm, Sweden (*)
  118. Nair, H. (2014) Using active Leptospermum honey and super-absorbent polymer dressing to promote wound healing in chronic diabetic foot ulcers: A pilot study. Symposium of Advanced Wound Care. Poster. (**)
  119. Nijhuis, WA (2012), et.Al. A randomised trial of honey barrier cream versus zinc oxide ointment British Journal of Nursing, (Tissue Viability Supplement), Vol 21, No 20. (^^)
  120. Oldfield, R. (2007) The utilisation of honey to promote wound bed preparation and healing in a patient with necrotic leg ulcer. Wounds UK Conference. Harrogate, UK. Nov. Poster.(**)
  121. Oldfield R. (2012) A Retrospective Audit of Referrals Received by the Tissue Viability Service Where Patients Were Treated with Active Leptospermum Honey Between January 2008 to July 2011. Spring SAWC conference. Atlanta. April. Poster.
  122. Pereira M. (2014) The use of Medihoney HCS on a degloved fungal infected foot and secondary bacterial infection: case study. Proceedings of Symposium Wounds UK, Nov., Harrogate, UK. Poster. (^^)
  123. Peters KL, Bowers-Guyon J, Ligouri PA, Senno S. (2011) The use of a new active Leptospermum Honey Gel under negative pressure wound therapy: a case series. Proceedings of Clinical Symposium of Advanced Wound Care, Sept. 2011, Washington DC, Poster (**)
  124. Pieper B. (2009) Honey-Based Dressings and Wound Care: An Option for Care in the United States.Journal of Wound, Ostomy and Continence Nursing, 36 (1): 60-66
  125. Posar S (2013), Cyclical Alternating Use of Cadexomer Iodine and Active Leptospermum Honey Dressings in Complex, Non- Healing, Biofilm Burdened Wounds. Proceedings of Symposium on Advanced Wound Care, Spring, Denver, CO. Poster. (**)
  126. Rabindranath K, Bansal T, Adams J, Das R, Shail R, MacLeod A, Moore C, Bersarab A. (2009) Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrology Dialysis Transplantation;24:3763-3774. (**)
  127. Raizmann, R. (2009). Evidence based practice for wound care: utilizing active Leptospermum honey as a primary dressing for wounds of varying etilology. Canadian Association of Wound Care Conference. Calgary, Canada. Poster.
  128. Raizmann, R. (2010). Evidence-based Practice: Utilizing Active Leptospermum Honey as a Primary Dressing for Wounds of Varying Etiologies. Wonders of Advancing Wound, Ostomy, Continence Nursing Care, Canadian Association of Enterostomal Therapy. Niagara Falls, Ontario. Poster.
  129. Regulski, M. (2008) Chronic lower extremity venous ulceration-use of Leptospermum honey impregnated alginate to facilitate wound closure. American Professional Wound Care Association Conference. Texas Poster.
  130. Regulski, M. (2008) A novel wound care dressing for chronic venous leg ulcerations. Podiatry Management. Nov/Dec. 235-246 (***)
  131. Reyna R. (2012) Various Uses of Active Leptospermum Honey on Neonatal/Pediatric Skin & Wound Problems. NICU RN Driscoll Children’s Hospital, Corpus Christi, Texas. September. Poster.
  132.  Reyna R. (2011) The use of active Leptospermum Honey in common paediatric wound etiologies. Proceedings of Symposium on Advanced Wound Care, Oct. 2011, Las Vegas, NV, Poster (*, ***, ****)
  133. Reyna, R. (2010) Active Leptospermum honey for pediatric wound care: Moving evidence into practice for pediatric wound care. American Professional Wound Care Association, Philadelphia, 8-11 April. Poster
  134. Reyna, R. (2010) Use of Active Leptospermum Honey for a Pediatric Patient with Hydradenitis Suppurativa.Ostomy Wound Management. May:12-15 (****)
  135. Reyna R. (2009) Active Leptospermum honey for pediatric wound care: moving evidence into practice. Proceedings of Wild on Wounds, Oct. 2009, Las Vegas, NV, Poster (****)
  136. Richards, L. (2002) Healing infected recalcitrant ulcers with Antibacterial Honey. Proceedings of 4th Australian Wound Management Association Conference. Adelaide, Australia. March. Poster. (*)
  137. Robson V, Yorke J, Sen R, Lowe D, Rogers S. (2012) Randomised controlled feasibility trial on the use of medical grade honey following microvascular free tissue transfer to reduce the incidence of wound infection. The British J Oral & Maxillofacial Surgery;50(4):321-327
  138. Robson, V. (2009) Providing evidence on the cost effectiveness of topical Antibacterial Honey dressing for formulary inclusion. Proceedings of. European Wound Management Association Conference. Finland. 19-21 May. Poster. (**)
  139. Robson, V. and Cooper, R. (2009) Using Leptospermum Honey to manage wounds impaired by radiotherapy: A case series. Ostomy Wound Management. 55(1):38-47 (*)
  140. Robson, V. and Dodd, S. (2009) Randomized clinical trial, comparing a standardised antibacterial honey (Medihoney™) with standard therapy in the management of wounds. Proceedings of. European Wound Management Association Conference. Finnland. 19-21 Mai. Poster. (**)
  141. Robson, V., Dodd, S. and Thomas, S. (2009) Standardized antibacterial honey (Medihoney™) with standard therapy in wound care: randomized clinical trial. Journal of Advanced Nursing. 65(3): 565-575. (*)
  142. Robson, V., Cooper, R.A. and Ehsan, M.E. (2007) The use of honey in wound management following ENT surgery. Primary Intention. 15. (4): 176-180 (*)
  143. Robson, V., Martin, L, and Cooper, R. (2005) The use of Leptospermum honey on chronic wounds in breast care. In R. White, R. Cooper and P. Molan (Eds.), HONEY: a modern wound management product . (pp 103-115). Aberdeen. Wounds UK publishing. (*)
  144. Robson, V., (2005) The use of Leptospermum honey in chronic wound management. In R. White, R. Cooper and P. Molan (Eds.), HONEY: a modern wound management product . (pp 79-88). Aberdeen. Wounds UK publishing. (*)
  145. Robson, V. (2005) The use of Leptospermum honey in slow to heal wounds. Proceedings of. European Wound Management Association Conference. Stuttgart. 15-17 Sept. Poster. (*)
  146. Robson, V. (2004) The use of Leptospermum honey in chronic wound management. J. Comm. Nurs. 18: 176-180 (*)
  147. Robson, V. (2002) Leptospermum honey used as a debriding Agent. Nurse 2 Nurse. 2. (11): 66-68. (*)
  148. Rothmeier N, Abu-Jawad J, Arnolds D, Arweiler-Harbeck D, Dominas N, Stein R, Zander S, Lang S, Mattheis S. (2014) The treatment of chronic wounds in the head and neck area after radiotherapy with medical honey. Laryngo-Rhino-Otol; 93: 612-618. (*)
  149. Ryan, M. (2008) The use of a medical grade honey (Leptospermum) in salvaging a lower limb in a post operative wound. Proceedings of Wounds UK. Harrogate, UK. Nov. poster (**)
  150. Sare, J. (2007) The use of topical medical honey antibacterial wound gel in leg ulcer management. Proceedings of European Wound Management Association Conference. Glasgow. Poster. (**)
  151. Sare, J. (2008) Leg ulcer management with topical medical honey. British Journal of Community Nursing. 13(9): s22-31.(**)
  152. Schimmer, C., Bensch, M., Sommer, S.P., Hanano, R., Elert, O. and Leyh, R. (2008) Treatment of deep sternal wound infection with V.A.C.® therapy in combination with local application of antibacterial honey (Medihoney(tm)). Proceedings of 5th joint annual meeting of the German, Austrian and Swiss Societies of Thorax and Cardiovascular Surgery. Innsbruck, Austria, February.(*)
  153. Schultis, B. (2014) Effectiveness of a Leptospermum Honey and a Novel Hydrogel Colloidal Sheet Dressing with Leptospermum Honey with Obstetrical and Gynecological Wounds and Incision Sites. Proceedings of Symposium on Advanced Wound Care, Orlando, FL. Poster. (****)
  154. Schultis, S. (2014) Effectiveness of Leptospermum honey dressings on obstetrical and gynecological surgical and other wounds. Symposium on Advanced Wound Care, Orlando, FL. Poster. (**)
  155. Schumacher, H.H.A. (2004) Use of medical honey in patients with chronic venous leg ulcers after split-skin grafting. Journal of Wound Care. 13. (10): 451-2.(*)
  156. Seckam A (2014), Case studies to demonstrate the use of Medihoney barrier cream to treat blisters. Proceedings of Wounds UK Conference, Nov., Harrogate, UK. Poster. (^^^)
  157. Seckam A (2013), Turkos M. Case reports to demonstrate the use of Medihoney™ Barrier Cream to treat atopic eczema. Proceedings of Wounds UK Conference, Nov., Harrogate, UK. Poster. (˄˄˄)
  158. Segovia, D. (2010) The clinical benefits of active Leptospermum honey: Oncologic wounds. American Professional Wound Care Association, Philadelphia, 8-11 April. Poster
  159. Senno, S.L., & Peters, K.L. (2009) Favorable treatment outcome utilizing combined active Leptospermum honey with NPWT to enhance removal of devitalized tissue and potentiate wound healing. Clinical Symposium on Advances in Skin and Wound Care. San Antonio, TX. Poster
  160. Shead C. (2013) Wound Bed Preparation using Medihoney Hydrogel Colloidal Sheet. Proceedings of Wounds UK Conference, Nov., Harrogate, UK. Poster. (˄˄)
  161. Sheikh E. Maggio D., Darby Z., Weber R. (2015) A Case Series Illustrating the Effect of Active Leptospermum Honey on Early Vs. Late Presentation Wounds. SAWC, San Antonio, Texas. Poster.
  162. Simon, A., Sofka, K., Wiszniewsky, G., Blaser, G., Bode, U. and Fleischhack, G. (2006) Wound care with antibacterial honey (Medihoney™) in pediatric hematology-oncology. Supportive Care in Cancer. 14. (1): 91-7.(*)
  163. Simon, A., Sofka, K., Wiszniewsky, G., Blaser G. (2006) Antibacterial honey (Medihoney®) for wound care of immunocompromised pediatric oncology patients. GMS Krankenhaushygiene Interdisziplinär. 1 (1)
  164. Simon, A., Blaser, G. & Santos, K. (2008) Honey in paediatric care and oncology. In Cooper, R., Molan, P. & White, R (eds), HONEY in modern wound management. (pp153-167). Aberdeen, Wounds UK
  165. Simon, A., Traynor, K., Santos, K., Blaser, G., Bode, U. and Molan, P. (2008) Medical Honey for Wound Care – still the „Latest Resort“? eCAM Advance Access. Evidence-Based Complementary and Alternative Medicine. Available at: http://ecam.oxfordjournals.org/cgi/content/full/nem175v1 (online) (*)
  166. Simon, M. (2014) Use of active Leptospermum honey to aide in promoting autolytic debridement and wound healing in challenging chronic wounds. Proceedings of Symposium of Advanced Wound Care, April, Orlando, FL. Poster. (**)
  167. Smith, T., Legel, K. and Hanft, J.R. (2009) Topical leptospermum Honey (Medihoney) in recalcitrant venous leg wounds: A preliminary case series. Advances in Skin and Wound Care. 22(2): 68-71.
  168. Smith, T. (2010) Management of wounds with antibacterial medical honey (Leptospermum spec) and topical negative pressure (TNP). Wounds UK. 6 (1): 143-146
  169. Spillman C. (2012) Wound Progress Using Honey Colloid Dressings with Active Leptospermum Honey in an Office Based Plastic Surgery Environment: A case study. Proceedings of Am Society of Plastic Surgery Nurses Conference, Oct. 2012, Washington DC, Poster (****)
  170. Stephen-Haynes J. (2011) Achieving Clinical Outcomes: The Use of Honey. Wound Essentials;6:14-19 (All Medihoney products)
  171. Sofka, K., Wiszniewsky, G., Blaser, G., Bode, U. and Simon, A. (2004) Antibakterielle Honig (MedihoneyTM) zur Wundpflege – Wundantisepsis bei pädiatrischen Patienten in der Hämatologie-Onkologie? [Antibacterial Honey (MedihoneyTM) for Woundcare – an antiseptic option for wound care in paediatric oncology?]. Krankenhaus-Hygiene und Infektionsverhütung. 26. (5):183-187. (*) (German)
  172. Stead, M. and Oldfield. A. (2007) Use of Honey in a Wound with TB. Proceedings of University Hospitals Coventry and Warwickshire NHS Trust tissue viability conference. Coventry, UK. December. Poster.(**)
  173. Stewart, J. (2002) Therapeutic honey used to reduce pain and bleeding associated with dressing change. Proceedings of 4th Australian Wound Management Association Conference. Adelaide, Australia. March. Poster.(*)
  174. Strilko, B., Barkauskas,C. McIntosh, A. and Reaney, N. (2008) Use of new active Leptospermum Honey dressings in non-healing wounds. Proceedings of Symposium of Advanced Wound Care San Diego, USA poster. (***)
  175. Strilko, B., Barkauskas, C., & McIntosh, A. (2010). A safe and effective alternative for debridement of lower extremity wounds: Active Leptospermum honey dressings. The Symposium on Advanced Wound Care and Wound Healing Society Meeting. Orlando, FL., USA. 17-20 April. Poster.
  176. Tavernelli, K. and Reif, S. (2008) The challenges of chronic venous leg ulcers and how leptospermum honey can help. Proceedings of World Union of Wound Healing Societies. Toronto, Canada. June. Poster.(***)
  177. Tavernelli, K., Reif, S., and Larsen, T. (2010). Managing venous leg ulcers in the home. Ostomy Wound
    Management, Februar, 10-11
  178. Thamboo A, Thamboo A, Philpott C, Javer A. (2011). Single-Blind Study of Manuka Honey in Allergic Fungal Rhinosinusitis. Journal of Otolaryngology-Head and Neck Surgery 2011;40(3):238-243. (*)
  179. Tolentino A. C., Cost-Analysis of Active Leptospermum Honey Calcium Alginate Dressing versus Silver Hydrofiber Dressing for Chronic Leg Ulcer Treatment Under the Brazilian Public Payer Perspective.
    SAWC, San Antonio, Texas. Poster.
  180. Tolentino A. C., Cost-Analysis of Active Leptospermum Honey Calcium Alginate Dressing versus Silver Hydrofiber Dressing for Chronic Leg Ulcer Treatment in Australia. SAWC, San Antonio, Texas. Poster.
  181. Traynor, K. (2007) The healing touch of honey. American Bee Journal. 147(6): 521-525
  182. Vlahovic, T.C. and Roberts, E. (2008) Active Leptospermum honey: treatment for various lower extremity dermatologic issues. Proceedings of Clinical Symposium of Advanced Wound Care. Las Vegas, USA. Oct. Poster
  183. Wall M. (2014) Medihoney HCS provides comfort and healing for a patient with painful leg ulcers. Proceedings of Symposium Wounds UK, Nov, Harrogate UK. Poster. (^^).
  184. Webb, M. (2008) Management of an MRSA colonized wound using active Leptospermum honey impregnated calcium alginate. Proceedings of 12th Annual Wound Care Congress. Florida, USA. Sept. Poster.(***)
  185. Webb, M. (2009) Use of active Leptospermum honey for wound bed preparation and healing in heavily infected multisite wounds at one public long term care facility. Proceedings of American professional Wound Care Association Conference. Philadelphia, USA, 2-4 April. Poster. (***)
  186. Webb, M. (2009) Selection of a cost effective debriding alternative to a pharmaceutical enzymatic agent at one county long term care facility. Proceedings of American professional Wound Care Association Conference. Philadelphia, USA, 2-4 April. Poster. (***)
  187. Weir, D. And Blakely, M. (2008) The voice of experience: wound management using active Leptospermum Honey impregnated calcium alginate dressing. Proceedings of World Union of Wound Healing Societies. Toronto, Canada. Poster. (***)
  188. Welber A., Celestin C. A., Farid M. M., Fernandez B. B., (2012) The Effectiveness of Active Leptospermum Honey and a Novel Super-Absorbent Hydrogel-Colloidal Sheet in Managing Challenging Lower Extremity Wounds; A Case Study Series. Spring SAWC conference. Atlanta. April. Poster.
  189. Welber A., Farid M. M., Celestin C. A., Fernandez B. B. (2012) A Sweet Solution to a Bitter Life Problem: The Use of Active Leptospermum Honey Wound and Burn Dressing in a Lower Extremity Chronic Lymphedema Patient: A Case Study. Spring SAWC conference. Atlanta. April. Poster.
  190. Welber A. (2013) The effectiveness of active Leptospermum honey and a novel super-absorbent hydrogel-colloidal sheet in managing challenging lower extremity wounds- a case series. Proceedings of NPUAP Conference, Feb, Texas. Poster. (^)
  191. Wells, K. (2014) Sam’s Story. Proceedings of Symposium Wounds UK Conference, Nov, Harrogate, UK. Poster. (^^^,^^,***)
  192. White, R. and Acton, C. (2006) Honey in modern wound management. MIMS Dermatology. 2. (1): 40-42. (**)
  193. Winkler M. J., Wisnieski L., Winkler S. M. (2012) Honey is synergistic with fuzzy wale elastic compression to improve healing of refractory venous leg ulcers. Spring SAWC conference. Atlanta. April. Poster.
  194. Wodash A. (2012) Finding Success with Active Leptospermum Honey After Failures with Negative Pressure Wound Therapy. Augustana Care Center, Minneapolis, Minnesota. September. Poster.
  195. Zeiger, B. (2010). The use of active Leptospermum honey dressings to re-initiate the wound healing process. Ostomy Wound Management, Januar

IN VITRO

  1. Blair, S. (2000) Honey and drug resistant pathogens. Proceedings of Joint Scientific Meeting of The Australian Society for Microbiology. Cairns, Australia. July.
  2. Blair, S.E., Cokcetin, N.N., Harry, E.J., Carter, D.A. (2009) The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. Eur J Clin Microbiol Infect Dis 28 (10): 1199-1208 (*)
  3. Camplin A, Maddocks S (2014). Manuka honey in treatment of biofilms of Pseudomonas aeruginosa results in the emergence of isolates with increased honey resistance. Annals of Clinical Microbiology and Antimicrobials, 13:19.
  4. Cooper, R.A., Jenkins, R. and Rowlands, R. (2008) The influence of catalase on the antibacterial activity of honey. Proceedings of Symposium on Advanced Wound Care. San Diego, CA. April. Poster.
  5. Cooper, R.A., Jenkins, L. (2009) A comparison between medical grade honey and table honeys in relation to antimicrobial efficacy;Wounds. 21 (2): 29-36 (**)
  6. Cooper, R.A., Jenkins, L., Henriques, A.F.M., Duggan, R.S. and Burton, N.F. (2010) Absence of bacterial resistance to medical-grade manuka honey. Eur. J. Clin. Microbiol. Infect. Dis. [Epub ahead of print]
  7. Cooper R, Jenkins L, Hooper S. (2014) Inhibition of Biofilms of Pseudomonas Aeruginosa by MEDIHONEY in Vitro. Journal of Wound Care: vol; 23, No.3, 93-104.
  8. George N., Cutting K. (2007) Antibacterial Honey(Medihoney™): in-vitro Activity Against Clinical Isolates of MRSA, VRE, and Other Multiresistant Gram-negative Organisms Including Pseudomonas aeruginosa; Wounds. 19. (9): 231 – 236 (*)
  9. George, N. (2004) Honey – Natural Antimicrobial. Proceedings of Australian Infection Control Association Third Biennial Conference. Hobart, Australia. June.
  10. Hammond EN, Donkor ES (2013). Antibacterial effect of Manuka honey on Clostridium difficile. BMC Res Notes, May 7; 6(1):188. (˄)
  11. Igelbrink, D., Koburger, T., Simon, A., Kramer A. (2007) Mikrobiozide Wirksamkeit von Medihoney™ [Microbiocidal efficacy of Medihoney™]. GMS Krankenhaushygiene Interdisziplinär 2 (2)
  12. Irish, J., Carter, D.A., Shokohi, T. and Blair, S. (2006) Honey has an antifungal effect against Candida species. Medical Mycology. 44. 289-291.
  13. Irish, J., Carter, D. and Blair, S. (2007) Honey prevents biofilm formation in Staphylococcus aureus. Proceedings of The Australian Society of Microbiology. Adelaide, Australia. Poster.
  14. Jenkins, R.E., Cooper, R.A. and Burton, N.F. (2008) A laboratory survey of the antimicrobial properties of honey-containing dressings. EWMA Journal. 8(3): 11-15. (***)
  15. Jenkins, R.E., Cooper, R.A. and Burton, N.F. (2008) The determination of antimicrobial activity of 3 honey impregnated wound dressings by challenge test with EMRSA-15. Proceedings of World Union of Wound Healing Societies. Toronto, Canada, June. Poster. (***)
  16. Jenkins R, Burton N, Cooper R. (2013) Proteomic and genomic analysis of methicillin-resistant Staphylococcus aureus (MRSA) exposed to manuka honey in vitro demonstrated down-regulation of virulence markers. J Antimicrobial Chemotherapy. Oct. Doi: 10.1093/jac/drt430. (*)
  17. Jenkins R, Cooper R. (2012) Improving Antibiotic Activity against Wound Pathogens with Manuka Honey In Vitro. Plos One [serial online]; 7(9):e45600.
  18. Jenkins RE, Cooper RA. (2013) Inhibiting biofilms of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa using combinations of manuka honey and antibiotics. Proceedings of Wounds UK Conference, Nov., Harrogate, UK. Poster. (**)
  19. Jenkins R, Cooper R. (2012) Synergy between oxacillin and manuka honey sensitizes methicillin-resistant Staphylococcus aureus to oxacillin. Journal of Antimicrobial Chemotherapy (JAC). June; 67(6):1405-1407. (*)
  20. Kronda JM, Cooper RA, Maddocks SE (2013) Manuka honey inhibits siderophore production in Pseudomonas aerginosa. J Applied Microbiology, Jul; 115(1): 86-90. Doi: 10.1111/jam.12222. (*)
  21. Lu J, Carter DA, Turnbull L, Rosendale D, Hedderley D, et al. (2013) The Effect of New Zealand Kanuka, Manuka and Clover Honeys on Bacterial Growth Dynamics and Cellular Morphology Varies According to the Species. PLoS ONE 8(2): e55898. doi:10.1371/journal.pone.0055898. (*)
  22. Lu et al. (2014), Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities. Peer J 2:e326; DOI 10.7717/peerj.326.
  23. Lusby, P.E., Coombes, A.L. and Wilkinson, J.M. (2005) Bactericidal activity of different honeys against pathogenic bacteria. Archives of Medical Research. 36. 454-467.
  24. Maddocks SE, Jenkins RE (2013) Honey: A sweet solution to the growing problem of antimicrobial resistance. Future Microbiology; 8(11): 1419-29. Doi: 10/2217/fmb.13.105. Review (*, **)
  25. Maddocks SE, Jenkins RE, Rowlands RS, Purdy KJ, Cooper RA (2013) Manuka honey inhibits adhesion and invasion of medically important bacteria (in vitro). Future Microbiol. Dec; 8: 1523-36. Doi: 10.2217/fmb.13.126 (*)
  26. Maddocks S, Lopez M, Rowlands R, Cooper R. (2012) Manuka honey inhibits the development of Streptococcus pyogenes biofilms and causes reduced expression of two fibronectin binding proteins. Microbiology (Reading, England) 2012;158(Pt 3):781-790.(*)
  27. Maddocks S, Purdy K, Cooper RA. (2013) Polymicrobial biofilms consisting of wound associated pathogens are susceptible to manuka honey treatment. Proceedings of Wounds UK Conference, Nov., Harrogate, UK. Poster. (**)
  28. Merckoll P., Jonassen T.O., Vad M.E., Jeansson S.L., Melby K.K. (2009) Bacteria, biofilm and honey: A study of the effects of honey on ‚planktonic‘ and biofilm-embedded chronic wound bacteria; Scand J Infect Dis. 41 (5): 341 -347 (*)
  29. Merckoll P., Jonassen T.O., Vad M.E., Jeansson S.L., Melby K.K. (2009) Wound bacteria, biofilm and honey: A real-time broth microtiter examination of the effects of Medihoney™ on bacterial growth and biofilm formation. Proceedings of. European Wound Management Association Conference. Finnland. 19-21
    Mai. Poster. (*)
  30. Müller P, Alber DG, Turnbull L, Schlothauer RC, Carter DA, et al. (2013) Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus (MRSA). PLoS ONE 8(2): e57679. doi:10.1371/journal.pone.0057679. (*)
  31. Okhiria OA, Henriques AFM, Burton NF, Cooper RA (2009). Honey modulates biofilms of Pseudomonas aeruginosa in a time and dose dependent manner. J ApiProd and ApiMed Sci. 1(1): 6-10. (*)
  32. Packer JM, Irish J, Herbert BR, Hill C, Padula M, Blair SE, Carter DA, Harry EJ (2012) Specific non-peroxide antibacterial effect of manuka honey on the Staphylococcus aureus proteome. Int J Antimicrobial Agents Jul; 40(1): 43-50. (˄)
  33. Schmidlin P, English H, Duncan W, Belibasakis G, Thurnheer T. (2014) Antibacterial potential of manuka honey against three oral bacteria in vitro. Swiss Dental Journal, 124: 922-927. (*)
  34. Sell S. (2012) The use of a combination of Manuka honey and platelet-rich plasma to stimulate dermal regeneration: In vitro evaluations. Proceedings of Biomedical Engineering Society Annual Meeting, 2012, Atlanta, GA, Poster (*)
  35. Sell S, Wolfe P. (2012) The potential for accelerated wound healing with Manuka honey and platelet-rich plasma. Proceedings of Regenerative Medicine: Harnessing Biology for Regenerative Medicine, 2012, Hilton Head, SC, Poster (*)
  36. Sell SA, Wolfe PS, Spence AJ, Rodriquez IA, McCool JM, Petrella RL, Garg K, Ericksen JJ, Bowlin GL (2012) A preliminary study on the potential of manuka honey and platelet-rich plasma in wound healing. Int J Biomaterials 2012: 313781. (*)
  37. Tirado D, Hudson N, Maldonado C (2014) Efficacy of medical grade honey against multidrug-resistant organisms of operational significance: Part 1. J Trauma Acute Care Surgery. Volume 77, Number 3, Supplement 2. (*)
  38. Tirado D, Maldonado C et. Al. (2013) Traumatic wound infection control & recovery: Combat zone applications of honey? Proceedings of Travis Air Force Base Research Symposium, Travis AFB, CA. Poster. (***)
  39. Tonks AJ, Dudley E, Porter N, Parton J, Brazier J, Smith E, Tonks A (2007) A 5.8kDa component of Manuka honey stimulates immune cells via TLR4. Journal of Leukocyte Biology; 82:1147-1155. (*)
  40. Wilkinson, J.M. and Cavanagh, M.A. (2005) Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa. Journal of Medicinal Food. 8. (1): 100-103.

Kontakt

Haben Sie Fragen, wollen Sie mehr erfahren?

Wir freuen uns über Ihre Interesse an Medihoney! 

Dafür nehmen wir uns gerne Zeit und stehen Ihnen mit Red und Antwort in allen Belangen zu den Medihoney Produkten zur Verfügung. Egal, ob eine Anregung, Erfahrungen, Nachfragen zur Anwendung oder auch Mangelinformationen. Wir freuen uns auf Ihren Kontakt.

Kontakt

Kontakt

Exklusivvertrieb der Medihoney-Wundheilprodukte in Deutschland

ApoFit Arzneimittelvertrieb GmbH
Jäckstr. 29
96052 Bamberg
Deutschland – Germany

Fon: +49 (0) 951 – 510 760 0
Fax: +49 (0) 951 – 510 760 29
E-Mail: info@apofit.de
Internet: www.apofit.de

Wichtiges

ApoFit Arzneimittelvertrieb GmbH © 2022. Alle Rechte vorbehalten